Concepedia

M. L. Cloud

ML

8

Publications

353

Citations

8

H-Index

1987

Active since

Affiliations

Eli Lilly (United States)(Current)

M. L. Cloud is an author at Eli Lilly (United States) specializing in pharmacotherapy, gastroenterology, and medicine.

Top concepts

Publications per year

1987–1998

8

Publications

8

Rabeprazole in Treatment of Acid Peptic Diseases (Results of Three Placebo-Controlled Dose-Response Clinical Trials in Duodenal Ulcer, Gastric Ulcer, and Gastroesophageal Reflux Disease (GERD))

M. L. Cloud, Nathan Enas, Thomas J. Humphries et al. · Digestive Diseases and Sciences · 1998 · 116 citations

, , +7

A Specific LTD <sub>4</sub> /LTE <sub>4</sub> receptor Antagonist Improves Pulmonary Function in Patients with Mild, Chronic Asthma

M. L. Cloud, G Enas, James Kemp et al. · American Review of Respiratory Disease · 1989 · 110 citations

Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.

M. L. Cloud, Walter Offen, Michael Robinson · PubMed · 1991 · 34 citations

, , +13

Nizatidine as Maintenance Therapy of Duodenal Ulcer Disease in Remission

Maurice A. Cerulli, M. L. Cloud, Walter Offen et al. · Scandinavian Journal of Gastroenterology · 1987 · 24 citations

Nizatidine versus placebo in gastroesophageal reflux disease

M. L. Cloud, Walter Offen · Digestive Diseases and Sciences · 1992 · 22 citations

, , +3

Rows per page

1–5 of 8